Definium Therapeutics DFTX
NASDAQ DFTX
$38.41 +2.24 (+6.19%)
At close: Sep 28, 2026 · 4:00 PM EDT

Definium Therapeutics (DFTX) Selling, General & Administrative (2021 - 2026)

Updated

Definium Therapeutics (DFTX) reported Selling, General & Administrative of $26.41 million for Q2 2026, up 138.1% from $11.09 million a year earlier and up 48.9% from the prior quarter.

Analysis

Definium Therapeutics (DFTX) Selling, General & Administrative (2021 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Definium Therapeutics' Selling, General & Administrative came in at $72.9 million, up 90.8% year-over-year; for FY2025, it came in at $48.64 million, up 26.0% from FY2024.

  • Selling, General & Administrative has a five-year compound annual growth rate of 27.6% (FY2020 to FY2025).
  • By year, Selling, General & Administrative came in at $38.62 million in FY2024 (-7.5%), $41.74 million in FY2023 (+38.4%), $30.16 million in FY2022 (-48.9%) and $59.07 million in FY2021 (+310.2%).
  • The Q2 2026 figure ranks as the highest quarterly Selling, General & Administrative since Q2 2021.
  • Year over year, Selling, General & Administrative has now increased in each of the last five quarters, with growth averaging 44.0% over the last eight quarters.
  • The high point for year-over-year Selling, General & Administrative in five years was Q2 2026 (growth of 138.1%); the low point was Q2 2022 (a decline of 79.5%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $17.74 million (Q1 2026), $14.06 million (Q4 2025) and $14.69 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Johnson & Johnson 653.54 Bn 572.07 Bn 17.26 Bn 6.43 Bn
2 AbbVie 467.01 Bn 440.17 Bn 12.70 Bn 3.63 Bn
3 Merck 367.16 Bn 321.59 Bn 12.21 Bn 2.90 Bn
4 Novartis Ag 277.56 Bn 233.43 Bn 11.24 Bn -3.24 Bn
5 Astrazeneca 258.23 Bn 231.79 Bn 12.86 Bn -5.65 Bn
6 Amgen 224.14 Bn 179.54 Bn 7.24 Bn 1.75 Bn
7 Gilead Sciences 187.30 Bn 161.42 Bn 6.22 Bn 1.92 Bn
8 Pfizer 163.47 Bn 110.41 Bn 10.94 Bn 3.41 Bn
9 Vertex Pharmaceuticals 133.31 Bn 105.31 Bn 2.84 Bn 582.20 Mn
10 Definium Therapeutics 4.00 Bn 4.00 Bn - 26.41 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 26.41 Mn
Mar 31, 2026 17.74 Mn
Dec 31, 2025 14.06 Mn
Sep 30, 2025 14.69 Mn
Jun 30, 2025 11.09 Mn
Mar 31, 2025 8.80 Mn
Dec 31, 2024 10.70 Mn
Sep 30, 2024 7.60 Mn
Jun 30, 2024 9.81 Mn
Mar 31, 2024 10.50 Mn
Dec 31, 2023 10.66 Mn
Sep 30, 2023 8.41 Mn
Jun 30, 2023 14.41 Mn
Mar 31, 2023 8.26 Mn
Dec 31, 2022 5.07 Mn
Sep 30, 2022 9.21 Mn
Jun 30, 2022 7.62 Mn
Mar 31, 2022 8.26 Mn
Dec 31, 2021 6.68 Mn
Sep 30, 2021 8.21 Mn
API Access

Definium Therapeutics Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=DFTX&period=max&api_key=YOUR_API_KEY